Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOGIC: Sulphonylurea Synergy with Incretins
NCT03705195Completed
- Sponsor
- University of Dundee
- Start
- Aug 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Dundee. Primary endpoint: Difference in insulin secretion and incretin effect between two matched clamps at 4 weeks. Started Aug 2018; status: completed.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03705195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705195.